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Introduction: We present an unusual presentation of a 39-year-old man with myalgias and 
shortness of breath.
Chief complaints: The patient presented to the emergency department with complaints of 
myalgias, shortness of breath and palpitations. During this hospitalization, he had multiple 
episodes of tachycardia and desaturation. The patient had elevated troponins and creatinine 
kinase. Differential diagnosis included pericarditis, pneumonia and malignancy.
Investigations: The patient had elevated ferritin and erythrocyte sedimentation rate.
Outcome: The patient had adult Still’s disease.
Lesson: This case shows how the presentation and symptom complex of Still’s disease together 
with the lack of specific serological markers can misguide the diagnosis.
Keywords: adult Still’s disease, rheumatology, hemophagocytic lymphohistiocytosis, 
immunology
Introduction
We present an unusual case of a 39-year-old man who presented to the emergency 
department with myalgias, shortness of breath, palpitations and fever with chills. Dur-
ing this hospitalization, he had multiple episodes of tachycardia and desaturation. The 
patient had elevated troponins and creatinine kinase. Differential diagnosis included 
pericarditis, pneumonia and malignancy. The patient had elevated ferritin and eryth-
rocyte sedimentation rate (ESR). This case shows how the presentation and symptom 
complex of Still’s disease together with the lack of specific serological markers can 
misguide the diagnosis. Early recognition of the florid manifestations will shorten 
hospital stay and avoid putting the patient through a battery of tests.
Case
A 39-year-old African-American man with a past medical history of type 2 diabetes 
mellitus and hyperlipidemia presented with stiffness, generalized myalgias, shortness 
of breath and irregular heart beat. The patient reported that the symptoms had progres-
sively worsened since onset (~1 week prior), which prompted him to seek emergent/
urgent medical care at the outside hospital. Here, he was treated for statin-induced 
rhabdomyolysis with ibuprofen, valium and vicodin and discharged home. After 3 days, 
he presented to our hospital with persistent and worsening myalgias (that were 4/10 in 
intensity). He also complained of stiffness that was more prominent in lower extremi-
ties, neck, shoulders and chest. Upon further history, he reported decreased oral fluid 
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intake and 3-day history of dyspnea on exertion. Medication 
history was significant for discontinuation of statins 2 months 
ago. Review of symptoms was positive for non-productive 
cough of 2 weeks duration, fatigue and nausea. He denied 
experiencing similar symptoms in the past, recent travel 
or consumption of any over-the-counter or herbal medica-
tions. Past medical history included diabetes mellitus (diet 
controlled), hyperlipidemia and regular alcohol use (2 beers 
per day). Review of systems was positive for intermittent 
fever, trouble swallowing and flank pain. On examination, 
he was febrile (temperature 39.5°C), tachycardic (116 bpm), 
tachypneic (30 cpm) and hypoxemic (requiring 4 L of oxygen 
to maintain oxygen saturation >90%). Diffuse tenderness was 
elicited in majority of the proximal muscle groups. He also 
had right parasternal chest tenderness and mild bilateral lower 
extremity swelling. Initial investigations showed a white cell 
count of 10.5 (absolute neutrophil count 9.4), normal basic 
metabolic panel, negative gram stain of urine, negative respi-
ratory virus panel, normal procalcitonin and creatinine kinase 
of 208. Based on initial evaluation, he was given a preliminary 
diagnosis of pneumonia and was started on 1 L of normal 
saline, intravenous antibiotics (ceftriaxone and azithromycin) 
and 4 L of oxygen via nasal cannula to keep his saturation 
>92%. Infectious workup revealed a negative sepsis screen, 
sputum, urine cultures, mononuclear test and normal lactic 
acid. He continued to have high spiking fevers, arthralgia, 
persistent tachycardia, chest pain worsened with deep breath-
ing and cramps in bilateral lower extremities. On further 
investigations, he was found to have elevated troponins and 
creatine kinase. Imaging performed to further evaluate the 
cause for shortness of breath included a negative chest X-ray 
and computed tomography angiography (CTA) chest con-
cerning multilobar pneumonia. As this was consistent with 
sepsis, he was continued on ceftriaxone and azithromycin for 
community-acquired pneumonia. Pericarditis was ruled out 
with transthoracic echocardiogram, which showed normal 
cardiac function and absence of any effusions. Tachycardia 
was thought to be likely due to anxiety and was managed 
with alprazolam 2 mg/pro re nata (PRN) or as needed. 
Infectious and autoimmune etiology were ruled out by the 
following tests:  hepatitis panel, human immunodeficiency 
virus antibody, Epstein–Barr virus, mycoplasma antibodies, 
anti-nuclear antibodies, anti-neutrophil cytoplasmic antibod-
ies, rheumatoid factor and anti-Jo-1 antibodies were negative. 
Elevated ferritin at 27,088 ng/mL, ESR at 105 mL/hour and 
C-reactive protein (CRP) at 344 µg/L were found. Patient 
continued to have persistent fevers. The search for a non-
infectious etiology to explain the fever was sought out on day 
6. Head and chest along with abdominal/pelvic CT showed 
no infectious etiology or evidence of malignancy. Hemo-
phagocytic lymphohistiocytosis (HLH) can cause a similar 
level of hyperferritinemia to adult Still’s disease (ASD) and 
was ruled out by the absence of leukopenia, lymphopenia 
and granulocytopenia. Also to be noted was the bone marrow 
biopsy that did not show any signs of hemophagocytosis. The 
patient continued to have aching sternal pain and tachycardia, 
raising concern for myocarditis with friction rub. He con-
tinued to have inconsistent fevers, episodes of desaturation 
and chest pain. He was started on colchicine and ibuprofen 
with transition to oral antibiotics. Based on elevated ferritin 
levels, persistent fevers and the lack of infectious foci, a 
diagnosis of adult-onset Still’s disease was made. This diag-
nosis was discussed among infectious disease, rheumatology, 
hematology–oncology and general medicine departments. 
It was confirmed by the fact that patient responded well to 
steroids. He was started on 1 mg/kg/day of prednisone with 
resolution of symptoms 2 days after start of therapy. The 
total length of stay was 9 days. The patient was scheduled 
for regular follow-up every 2 weeks. We continued tapering 
doses of prednisone with the goal of 10 mg/day at the end of 
7 weeks. At the end of 8 weeks, the patient did not have any 
flares and complained of some mild joint pain occasionally. 
Over the next 3 months, the patient continued a maintenance 
dose of 10 mg prednisone daily. He was seen in follow-up 
visits and was doing well with no complaints or flares. He 
was then gradually transitioned to the disease-modifying 
anti-rheumatic drug (DMARD) anakinra. Written informed 
consent was received from the patient.
Discussion
This case highlights the florid manifestations and challenges 
in diagnosing Still’s disease. A patient presenting with quotid-
ian fevers, evanescent rash and various types of arthritis is the 
typical presentation of ASD or systemic juvenile  idiopathic 
arthritis.1 The etiology is currently proposed as a mix of 
genetic factors (human leukocyte antigen [HLA] – B17, 
HLA – B18, HLA – B35 and HLA – DR2) and infectious 
triggers (Rubella, Parvovirus B19, Yersinia enterocolitica).2–5 
Still’s is a rare disease (incidence of 0.16/100,000 persons) 
with bimodal age distribution between ages 15–25 and 
36–46.6 The disease has 3 presentations: monophasic type, 
intermittent type, and chronic articular type. Major presenting 
symptoms are quotidian fever, evanescent salmon colored 
rash and oligo- or poly-arthritis for all 3 types.7 Myalgia 
occurs with fever spikes and can be severe and debilitating. 
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Case report of atypical Still’s disease
is fusion of wrist joints. Other symptoms include a severe, 
non-suppurative pharyngitis (found in 69% of cases), hepato-
megaly (12–45%), elevated transaminases (75%), abdominal 
pain (1–48%) and cardiopulmonary disease (30–40%) such 
as pericarditis, pleural effusions and transient pulmonary 
infiltrates. Rarely renal, ophthalmic and neural involvement is 
also observed. Laboratory abnormalities include elevation of 
CRP, ESR and serum ferritin. Aspartate transaminase (AST) 
and alanine transaminase (ALT) are elevated with the disease 
and are further elevated upon the use of non-steroidal anti-
inflammatory drugs (NSAIDs) in the treatment. Hematologic 
manifestations include lymphocytosis with neutrophilia, 
normocytic normochromic anemia and thrombocytosis, 
microangiopathic hemolytic anemia, thrombotic thrombocy-
topenic purpura (TTP)–hemolytic-uremic syndrome (HUS) 
and disseminated intravascular coagulation (DIC). Diagnostic 
criteria of Still’s disease are given in Table 1.8–11
Monophasic type has a single flare of disease that lasts 
between weeks to months, and then the disease usually 
 completely resolves. Intermittent type flares last between 
several weeks to 1 or 2 years with one or more disease flares, 
and this type completely resolves as well. Chronic articular 
type patients have a persistently active disease, which usually 
evolves from monophasic or intermittent type. Treatment 
options and classification of disease are given in Table 2.
Of the numerous complications of Still’s disease, the most 
serious is HLH. HLH is a syndrome associated with exces-
sive immune activation. Macrophages, natural killer cells and 
cytotoxic lymphocytes are excessively activated with inad-
equate or absent down regulation. HLH symptoms include 
hepatomegaly, lymphadenopathy, neurological manifestation 
and rash. In the presence of HLH along with ASD, an attempt 
should be made to treat ASD provided the patient is stable, 
as the treatment of HLH involves drugs with many side 
effects including dexamethasone, etoposide,  methotrexate 
and in some cases cyclosporine. In an unstable patient, 
therapy should be directed toward resolving HLH. It is also 
prudent to remember that NSAIDs used in the  treatment of 
ASD are one of the potential triggers of MAS. MAS is a rare 
Table 1 Diagnostic criteria of Still’s disease
Five of the following criteria should be met for a diagnosis of ASD. Two 
criteria must be major
Major criteria
1. Fever of at least 39°C (102.2°F) lasting at least 1 week
2. Arthralgias or arthritis lasting 2 weeks or longer
3. A non-pruritic macular or maculopapular skin rash that is 
salmon-colored in appearance and usually found over the trunk or 
extremities during febrile episodes




3. Hepatomegaly or splenomegaly
4. Abnormal liver function studies, particularly elevations in AST, ALT 
and LDH concentrations
5. Negative tests for ANA and RF
Abbreviations: ASD, adult Still’s disease; AST, aspartate transaminase; ALT, 
alanine transaminase; LDH, lactate dehydrogenase; ANA, anti-nuclear antibody; RF, 
rheumatoid factor.
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 complication of ASD and falls within the spectrum of HLH. 
It is similar to HLH in manifestations, but it usually arises as 
a complication of ASD and fulfills Yamaguchi classification 
criteria for Still’s disease.12–14
Prognosis is generally good for patients suffering from 
ASD with 90% of the patients being able to perform daily 
activities even when they are suffering from chronic type dis-
ease. Immediate identification of ASD is very important. The 
presentation and complications of the disease are florid. High 
index of suspicion for the characteristic signs and symptoms 
will help in early identification and reduce a great amount of 
discomfort. We suggest a classification of the patient based on 
disease severity and immediate treatment to reduce the rate 
of complications. This presentation is unique with pneumo-
nia, myalgias and tachycardia as prominent symptoms. As a 
result, a search for other possible etiologies explaining the 
patient symptoms was carried out. This illustrates the point 
that Still’s disease with its complications is still a diagnostic 
conundrum in spite of well-researched diagnostic guidelines. 
Physicians should be aware of this kind of presentation with 
pneumonia and tachycardia.
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